CNTX - Context Therapeutics Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 8.46M
Enterprise value -21.28M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.23
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.18

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-60.71%
S&P500 52-week change 31.77%
52-week high 32.5200
52-week low 30.4700
50-day moving average 30.6113
200-day moving average 30.9968

Share statistics

Avg vol (3-month) 3120.97k
Avg vol (10-day) 3253.16k
Shares outstanding 515.97M
Implied shares outstanding 6N/A
Float 810.99M
% held by insiders 16.82%
% held by institutions 123.80%
Shares short (14 May 2023) 499.97k
Short ratio (14 May 2023) 41.13
Short % of float (14 May 2023) 40.67%
Short % of shares outstanding (14 May 2023) 40.63%
Shares short (prior month 13 Apr 2023) 4111.03k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-28.65%
Return on equity (ttm)-47.77%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-17.71M
Diluted EPS (ttm)-1.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)29.77M
Total cash per share (mrq)1.87
Total debt (mrq)31.67k
Total debt/equity (mrq)0.11
Current ratio (mrq)9.86
Book value per share (mrq)1.80

Cash flow statement

Operating cash flow (ttm)-15.46M
Levered free cash flow (ttm)-10.06M